Your browser doesn't support javascript.
loading
Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model.
Chen, Chin-Chang; Lee, Tzung-Yan; Kwok, Ching-Fai; Hsu, Yung-Pei; Shih, Kuang-Chung; Lin, Yan-Jie; Ho, Low-Tone.
Afiliação
  • Chen CC; Institute of Physiology, National Yang-Ming University, Taipei, Taiwan.
  • Lee TY; Graduate Institute of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Kwok CF; Graduate Institute of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Hsu YP; Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Shih KC; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Lin YJ; Department of Medicine-Metabolism, Cheng Hsin General Hospital, Taipei, Taiwan.
  • Ho LT; Department of Research Planning and Development, National Health Research Institutes, Miaoli, Taiwan.
Proteomics ; 17(1-2)2017 01.
Article em En | MEDLINE | ID: mdl-27928909
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Pirazóis / Biomarcadores / Proteômica / Receptores de Canabinoides / Antagonistas de Receptores de Canabinoides / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Pirazóis / Biomarcadores / Proteômica / Receptores de Canabinoides / Antagonistas de Receptores de Canabinoides / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article